G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer

[1]  A. Rangarajan,et al.  AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation , 2018, Journal of Cell Science.

[2]  H. Dressman,et al.  Orphan Adhesion GPCR GPR64/ADGRG2 Is Overexpressed in Parathyroid Tumors and Attenuates Calcium‐Sensing Receptor‐Mediated Signaling , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  T. Mitsui,et al.  AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis , 2016, Scientific Reports.

[4]  A. IJzerman,et al.  The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migration. , 2015, Cellular signalling.

[5]  M. Loda,et al.  Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies , 2015, Molecular Cancer Research.

[6]  M. Young,et al.  Targeting AMPK for cancer prevention and treatment , 2015, Oncotarget.

[7]  G. Mills,et al.  Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. , 2014, Cancer research.

[8]  S. Fulda,et al.  G‐Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1 , 2013, The Journal of pathology.

[9]  J. Gilleron,et al.  Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases , 2012, Cellular and Molecular Life Sciences.

[10]  Daohong Chen,et al.  Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus , 2012, PloS one.

[11]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[12]  A. Ashworth,et al.  Emerging therapeutic targets in endometrial cancer , 2011, Nature Reviews Clinical Oncology.

[13]  C. Naus,et al.  Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.

[14]  Vera Rogiers,et al.  Ca(2+) regulation of connexin 43 hemichannels in C6 glioma and glial cells. , 2009, Cell calcium.

[15]  P. Vandenabeele,et al.  Connexin-related signaling in cell death: to live or let die? , 2009, Cell Death and Differentiation.

[16]  M. Sułkowska,et al.  Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas. , 2008, Tissue & cell.

[17]  C. Kirchhoff,et al.  HE6/GPR64 adhesion receptor co-localizes with apical and subapical F-actin scaffold in male excurrent duct epithelia. , 2008, Reproduction.

[18]  E. Keystone,et al.  Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity , 2007, Genes and Immunity.

[19]  S. Tanguy,et al.  The role of connexins in controlling cell growth and gene expression. , 2007, Progress in biophysics and molecular biology.

[20]  S. Herrero-González,et al.  Tolbutamide reduces glioma cell proliferation by increasing connexin43, which promotes the up‐regulation of p21 and p27 and subsequent changes in retinoblastoma phosphorylation , 2006, Glia.

[21]  M. Behnen,et al.  Role of epididymal receptor HE6 in the regulation of sperm microenvironment , 2006, Molecular and Cellular Endocrinology.

[22]  U. Habenicht,et al.  New approaches for male fertility control: HE6 as an example of a putative target , 2006, Molecular and Cellular Endocrinology.

[23]  M. Mesnil,et al.  Defective gap junctional intercellular communication in the carcinogenic process. , 2005, Biochimica et biophysica acta.

[24]  Shuguang Huang,et al.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. , 2005, International journal of oncology.

[25]  L. D. White,et al.  Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. , 2005, Endocrinology.

[26]  D. Laird,et al.  Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. , 2005, Cancer research.

[27]  H. Yamasaki,et al.  Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. , 2004, Carcinogenesis.

[28]  R. Ivell,et al.  Targeted Deletion of the Epididymal Receptor HE6 Results in Fluid Dysregulation and Male Infertility , 2004, Molecular and Cellular Biology.

[29]  M. C. Brañes,et al.  Plasma membrane channels formed by connexins: their regulation and functions. , 2003, Physiological reviews.

[30]  Kathleen R. Cho,et al.  Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. , 2003, Cancer research.

[31]  R. Heller,et al.  HE6, a two‐subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia , 2003, Molecular reproduction and development.

[32]  K. Willecke,et al.  An Update on Connexin Genes and their Nomenclature in Mouse and Man , 2003, Cell communication & adhesion.

[33]  J. Campisi.  Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[34]  J. Holbrook,et al.  Bioinformatics and type II G-protein-coupled receptors. , 2001, Biochemical Society transactions.

[35]  Tsuyoshi Saito,et al.  Suppressed gap junctional intercellular communication in carcinogenesis of endometrium , 2001, International journal of cancer.

[36]  C. Der,et al.  Rho GTPase-dependent transformation by G protein-coupled receptors , 2001, Oncogene.

[37]  D. Kaufman,et al.  Changes in connexin 43 protein expression in human endometrial carcinoma. , 1999, Experimental and molecular pathology.

[38]  N. Gilula,et al.  The Gap Junction Communication Channel , 1996, Cell.

[39]  P. Ao,et al.  Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[40]  R. Strange,et al.  Apoptosis in the genesis and prevention of cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  G. Nicolson.  Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.

[42]  W. Loewenstein,et al.  Growth inhibition of transformed cells correlates with their junctional communication with normal cells , 1986, Cell.

[43]  R. Kurman,et al.  The behavior of endometrial hyperplasia. A long‐term study of “untreated” hyperplasia in 170 patients , 1985 .

[44]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[45]  D. Thanapprapasr,et al.  Molecular therapy as a future strategy in endometrial cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[46]  C. Naus,et al.  Gap Junction Communication , 2009 .

[47]  Edgar Rivedal,et al.  Downregulation of gap junctions in cancer cells. , 2006, Critical reviews in oncogenesis.

[48]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[49]  S. D. Mearses.  ENDOMETRIAL CARCINOMA. , 1963, The Medical journal of Malaya.

[50]  L. Ellenson,et al.  Endometrial carcinoma. , 2007, Annual review of pathology.